{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:49:22Z","timestamp":1758970162970},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"University of szeged, Faculty of Medicine: PhD Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0586-7","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T16:50:18Z","timestamp":1464108618000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-\u03b1, IL-6, and IL-10 in the spinal cord and serum of mice"],"prefix":"10.1186","volume":"13","author":[{"given":"Izabella","family":"Ob\u00e1l","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gergely","family":"Klausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette","family":"M\u00e1ndi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ria","family":"Deli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Sikl\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef I.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,24]]},"reference":[{"key":"586_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmg.2014.01.002","volume":"57","author":"J Finsterer","year":"2014","unstructured":"Finsterer J, Burgunder JM. Recent progress in the genetics of motor neuron disease. Eur J Med Genet. 2014;57:103\u201312.","journal-title":"Eur J Med Genet"},{"key":"586_CR2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cge.12117","volume":"83","author":"M Sabatelli","year":"2014","unstructured":"Sabatelli M, Conte A, Zollino M. Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin Genet. 2014;83:408\u201316.","journal-title":"Clin Genet"},{"key":"586_CR3","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","volume":"22","author":"A Plaitakis","year":"1987","unstructured":"Plaitakis A, JT Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1987;22:575\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"586_CR4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","volume":"28","author":"JD Rothstein","year":"1990","unstructured":"Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28(1):18\u201325.","journal-title":"Ann Neurol"},{"key":"586_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","volume":"38","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD, Kammen MV, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38:73\u201384.","journal-title":"Ann Neurol"},{"key":"586_CR6","doi-asserted-by":"crossref","first-page":"861231","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J. Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014;2014:861231. doi: 10.1155\/2014\/861231.Epub2014May212014 .","journal-title":"Mediators Inflamm"},{"key":"586_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","volume":"18","author":"LI Bruijn","year":"1997","unstructured":"Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327\u201338.","journal-title":"Neuron"},{"issue":"12","key":"586_CR8","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.93.12.5709","volume":"93","author":"MB Yim","year":"1996","unstructured":"Yim MB, Kang JH, Kwak SH, Chock PB, Stadtman ER. A gain of function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in km for hydrogen peroxide. Proc Natl Acad Sci U S A. 1996;93(12):5709\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"586_CR9","doi-asserted-by":"crossref","first-page":"I17","DOI":"10.1007\/BF03161151","volume":"247","author":"PJ Shaw","year":"2000","unstructured":"Shaw PJ, Eggett CJ. Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol. 2000;247 Suppl 1:I17\u201327.","journal-title":"J Neurol"},{"key":"586_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0092-8674(93)90157-L","volume":"73","author":"Z Xu","year":"1993","unstructured":"Xu Z, Cork LC, Griffin JW, Cleveland DW. Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell. 1993;73:23\u201333.","journal-title":"Cell"},{"issue":"12","key":"586_CR11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/82122","volume":"6","author":"DW Cleveland","year":"2000","unstructured":"Cleveland DW, Liu J. Oxidation versus aggregation-how do SOD1 mutants cause ALS? Nat Med. 2000;6(12):1320\u20131.","journal-title":"Nat Med"},{"key":"586_CR12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1073\/pnas.88.2.647","volume":"88","author":"SH Appel","year":"1991","unstructured":"Appel SH, Engelhardt JI, Garcia J, Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci U S A. 1991;88:647\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR13","doi-asserted-by":"crossref","first-page":"497080","DOI":"10.1155\/2011\/497080","volume":"2011","author":"MR Pagani","year":"2011","unstructured":"Pagani MR, Gonzalez LE, Uchitel OD. Autoimmunity in amyotrophic lateral sclerosis past and present. Neurol Res Int. 2011;2011:497080. doi: 10.1155\/2011\/497080 . Epub 2011 Aug 1. 2011, 1-11. 2011.","journal-title":"Neurol Res Int"},{"issue":"6","key":"586_CR14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","volume":"71","author":"F Rizzo","year":"2014","unstructured":"Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, et al. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci. 2014;71(6):999\u20131015. doi: 10.1007\/s00018-013-1480-4 . Epub 2013 Oct 8. 71, 999-1015.","journal-title":"Cell Mol Life Sci"},{"key":"586_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuint.2004.10.002","volume":"46","author":"G Sala","year":"2005","unstructured":"Sala G, Beretta S, Ceresa C, Mattavelli L, Zoia C, Tremolizzo L, et al. Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis. Neurochem Int. 2005;46:227\u201334.","journal-title":"Neurochem Int"},{"key":"586_CR16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.1107","volume":"36","author":"Y Doung","year":"2001","unstructured":"Doung Y, Benveniste EN. Immune function of astrocytes. Ref Type: generic. Glia. 2001;36:180\u201390.","journal-title":"Glia"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2004.05.003","volume":"47","author":"LH Barbeito","year":"2004","unstructured":"Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev. 2004;47:263\u201374.","journal-title":"Brain Res Brain Res Rev"},{"key":"586_CR18","first-page":"2999","volume":"144","author":"Y Chung","year":"1990","unstructured":"Chung Y, Benveniste EN. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Neuroimmunol. 1990;144:2999\u20133007.","journal-title":"J Neuroimmunol"},{"key":"586_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ana.10805","volume":"55","author":"JS Henkel","year":"2004","unstructured":"Henkel JS, Engelhardt JI, Sikl\u00f3s L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221\u201335.","journal-title":"Ann Neurol"},{"key":"586_CR20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2990.1990.tb01276.x","volume":"16","author":"D Troost","year":"1990","unstructured":"Troost D, Van den Oord JJ, Vianney de Jong JM. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 1990;16:401\u201310.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"586_CR21","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140:691\u2013707.","journal-title":"Am J Pathol"},{"key":"586_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/14660820410020286","volume":"5","author":"MC Graves","year":"2004","unstructured":"Graves MC, Fiala M, Dinglasan LA, Liu NQ, Sayre J, Chiappelli F, et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:213\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"49","key":"586_CR23","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","volume":"106","author":"IM Chiu","year":"2009","unstructured":"Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci U S A. 2009;106(49):20960\u20135. doi: 10.1073\/pnas.0911405106 . Epub 2009 Nov 20.106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"586_CR24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.1990.00530110068019","volume":"47","author":"JI Engelhardt","year":"1990","unstructured":"Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol. 1990;47:1210\u20136.","journal-title":"Arch Neurol"},{"key":"586_CR25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0404.2005.00445.x","volume":"112","author":"JI Engelhardt","year":"2005","unstructured":"Engelhardt JI, So\u00f3s J, Ob\u00e1l I, Vigh L, Sikl\u00f3s L. Subcellular localization of IgG from the sera of ALS patients in the nervous system. Acta Neurol Scand. 2005;112:126\u201333.","journal-title":"Acta Neurol Scand"},{"key":"586_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/syn.890200302","volume":"20","author":"JI Engelhardt","year":"1995","unstructured":"Engelhardt JI, Sikl\u00f3s L, K\u00f6m\u00fcves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse. 1995;20:185\u201399.","journal-title":"Synapse"},{"key":"586_CR27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(00)00427-5","volume":"180","author":"AH Pullen","year":"2000","unstructured":"Pullen AH, Humphreys P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals or disease controls. J Neurol Sci. 2000;180:35\u201345.","journal-title":"J Neurol Sci"},{"issue":"5","key":"586_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1034\/j.1600-0404.2002.01252.x","volume":"106","author":"I Ob\u00e1l","year":"2002","unstructured":"Ob\u00e1l I, Sikl\u00f3s L, Engelhardt JI. Altered calcium in motoneurons by IgG from human motoneuron diseases. Acta Neurol Scand. 2002;106(5):282\u201391.","journal-title":"Acta Neurol Scand"},{"key":"586_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.410390210","volume":"39","author":"L Sikl\u00f3s","year":"1996","unstructured":"Sikl\u00f3s L, Engelhardt J, Harati Y, Smith RG, Jo\u00f3 F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:203\u201316.","journal-title":"Ann Neurol"},{"key":"586_CR30","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1097\/00001756-200108080-00032","volume":"12","author":"I Ob\u00e1l","year":"2011","unstructured":"Ob\u00e1l I, Jakab JS, Sikl\u00f3s L, Engelhardt JI. Recruitment of activated microglia cells in the spinal cord of mice by ALS IgG. Neuroreport. 2011;12:2449\u201352.","journal-title":"Neuroreport"},{"key":"586_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1471-4159.2005.03184.x","volume":"94","author":"M Demestre","year":"2014","unstructured":"Demestre M, Pullen A, Orrell RW, Orth M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem. 2014;94:268\u201375.","journal-title":"J Neurochem"},{"key":"586_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00005072-199701000-00003","volume":"56","author":"JI Engelhardt","year":"1997","unstructured":"Engelhardt JI, Siklos L, Appel SH. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol. 1997;56:21\u201339.","journal-title":"J Neuropathol Exp Neurol"},{"key":"586_CR33","doi-asserted-by":"crossref","first-page":"e89596","DOI":"10.1371\/journal.pone.0089596","volume":"9","author":"C May","year":"2014","unstructured":"May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, et al. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. Plos One. 2014;9:e89596. doi: 10.1371\/journal.pone.0089596 .","journal-title":"Plos One"},{"issue":"1","key":"586_CR34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.158.1.438","volume":"158","author":"K Akassoglou","year":"1997","unstructured":"Akassoglou K, Probert L, Kontogeorgos G, Kollias G. Astrocyte specific but not neuron specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol. 1997;158(1):438\u201345.","journal-title":"J Immunol"},{"issue":"21","key":"586_CR35","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1073\/pnas.90.21.10061","volume":"90","author":"IL Campbell","year":"1993","unstructured":"Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A. 1993;90(21):10061\u20135.91. 10061-5.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"586_CR36","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.95.19.11354","volume":"95","author":"C Chavany","year":"1998","unstructured":"Chavany C, Vicario-Abej\u00f3n C, Miller G, Jendoubi M. Transgenic mice for interleukin 3 develop motor neuron degeneration associated with autoimmune reaction against spinal cord motor neurons. Proc Natl Acad Sci U S A. 1998;95(19):11354\u20139.95. 11354-59.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"586_CR37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0304-3940(00)01177-0","volume":"287","author":"M Poloni","year":"2000","unstructured":"Poloni M, Facchetti D, Mai R, Micheli A, Agnoletti L, Francolini G, et al. Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett. 2000;287(3):211\u20134.","journal-title":"Neurosci Lett"},{"key":"586_CR38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-510X(01)00514-7","volume":"187","author":"S Ono","year":"2001","unstructured":"Ono S, Hu J, Shimizu N, Imai T, Nakagawa H. Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci. 2001;187:27\u201334.","journal-title":"J Neurol Sci"},{"key":"586_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-510X(97)00228-1","volume":"154","author":"T Sekizawa","year":"1998","unstructured":"Sekizawa T, Openshaw H, Ohbo K, Sugamura K, Itoyama Y, Niland JC. Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J Neurol Sci. 1998;154:194\u20139.","journal-title":"J Neurol Sci"},{"key":"586_CR40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/cyto.2002.2005","volume":"20","author":"J I\u0142zecka","year":"2002","unstructured":"I\u0142zecka J, Stelmasiak Z, Dobosz B. Transforming growth factor-Beta 1 (tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine. 2002;20:239\u201343.","journal-title":"Cytokine"},{"issue":"6","key":"586_CR41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0404.2010.01333.x","volume":"122","author":"M Rentzos","year":"2010","unstructured":"Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, et al. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: a reflection of Th17 cells activation? Acta Neurol Scand. 2010;122(6):425\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"586_CR42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000287582","volume":"63","author":"M Rentzos","year":"2010","unstructured":"Rentzos M, Rombos A, Nikolaou C, Zoga M, Zouvelou V, Dimitrakopoulos A, et al. Interleukin-15 and interleukin-12 are elevated in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur Neurol. 2010;63(5):285\u201390.","journal-title":"Eur Neurol"},{"issue":"2","key":"586_CR43","first-page":"139","volume":"9","author":"P Ghezzi","year":"1998","unstructured":"Ghezzi P, Bernardini R, Giuffrida R, Bellomo M, Manzoni C, Comoletti D, et al. Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur Cytokine Netw. 1998;9(2):139\u201344.","journal-title":"Eur Cytokine Netw"},{"issue":"1-2","key":"586_CR44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0169-328X(01)00242-X","volume":"95","author":"JL Elliot","year":"2001","unstructured":"Elliot JL. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res. 2001;95(1-2):172\u20138.","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"586_CR45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0969-9961(03)00087-1","volume":"14","author":"K Hensley","year":"2003","unstructured":"Hensley K, Fedynyshyn J, Ferrell S, Floyd RA, Gordon B, Grammas P, et al. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol Dis. 2003;14(1):74\u201380.","journal-title":"Neurobiol Dis"},{"issue":"16","key":"586_CR46","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1097\/00001756-200411150-00016","volume":"15","author":"Y Xie","year":"2004","unstructured":"Xie Y, Weydt P, Howland DS, Kliot M, M\u00f6ller T. Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. Neuroreport. 2004;15(16):2513\u20136.","journal-title":"Neuroreport"},{"issue":"2","key":"586_CR47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1471-4159.2002.00968.x","volume":"82","author":"K Hensley","year":"2002","unstructured":"Hensley K, Floyd RA, Gordon B, Mou S, Pye QN, Stewart C, et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem. 2002;82(2):365\u201374.","journal-title":"J Neurochem"},{"issue":"5","key":"586_CR48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"1","key":"586_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-5728(90)90132-7","volume":"27","author":"JI Engelhardt","year":"1990","unstructured":"Engelhardt JI, Appel SH, Killian JM. Motor neuron destruction in guinea pigs immunized with bovine spinal cord ventral horn homogenate: experimental autoimmune gray matter disease. J Neuroimmunol. 1990;27(1):21\u201331.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"586_CR50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000097283","volume":"3","author":"LC Gahring","year":"1996","unstructured":"Gahring LC, Carlson NG, Kulmar RA, Rogers SW. Neuronal expression of tumor necrosis factor alpha in the murine brain. Neuroimmunomodulation. 1996;3(5):289\u2013303.","journal-title":"Neuroimmunomodulation"},{"issue":"9","key":"586_CR51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nbt.1957","volume":"29","author":"AM Haidet-Phillips","year":"2011","unstructured":"Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824\u20138. doi: 10.1038\/nbt.1957 .","journal-title":"Nat Biotechnol"},{"issue":"4","key":"586_CR52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11481-013-9489-x","volume":"8","author":"W Zhao","year":"2013","unstructured":"Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8(4):888\u201399. doi: 10.1007\/s11481-013-9489-x . Epub 2013 Jul 25.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"586_CR53","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.nbd.2012.07.008","volume":"48","author":"W Zhao","year":"2012","unstructured":"Zhao W, Beers DR, Liao B, Henkel JS, Appel SH. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol Dis. 2012;48(3):418\u201328. doi: 10.1016\/j.nbd.2012.07.008 . Epub 2012 Jul 17.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"586_CR54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clim.2013.04.010","volume":"148","author":"M Saresella","year":"2013","unstructured":"Saresella M, Piancone F, Tortorella P, Marventano I, Gatti A, Caputo D, et al. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin Immunol. 2013;148(1):79\u201388. doi: 10.1016\/j.clim.2013.04.010 . Epub 2013 Apr 23.","journal-title":"Clin Immunol"},{"issue":"9","key":"586_CR55","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8(9):942\u20139. Epub 2007 Aug 5.","journal-title":"Nat Immunol"},{"issue":"5","key":"586_CR56","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878\u201388. doi: 10.1016\/j.bbamcr.2011.01.034 . Epub 2011 Feb 4.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"586_CR57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","volume":"39","author":"S Diehl","year":"2002","unstructured":"Diehl S, Rinc\u00f3n M. The two faces of IL-6 on Th1\/Th2 differentiation. Mol Immunol. 2002;39(9):531\u20136.","journal-title":"Mol Immunol"},{"issue":"7","key":"586_CR58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.molimm.2008.12.014","volume":"46","author":"MH Sofi","year":"2009","unstructured":"Sofi MH, Li W, Kaplan MH, Chang CH. Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production. Mol Immunol. 2009;46(7):1443\u201350. doi: 10.1016\/j.molimm.2008.12.014 . Epub 2009 Jan 31.","journal-title":"Mol Immunol"},{"issue":"4","key":"586_CR59","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.179.4.2041","volume":"179","author":"S Dominitzki","year":"2007","unstructured":"Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, et al. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+ CD25 T cells. J Immunol. 2007;179(4):2041\u20135.","journal-title":"J Immunol"},{"issue":"44","key":"586_CR60","doi-asserted-by":"crossref","first-page":"18126","DOI":"10.1073\/pnas.1110689108","volume":"108","author":"P D\u00edaz-Amarilla","year":"2011","unstructured":"D\u00edaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Mart\u00ednez-Palma L, Cassina P, et al. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2011;108(44):18126\u201331. doi: 10.1073\/pnas.1110689108 . Epub 2011 Oct 18.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"586_CR61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2012.06.011","volume":"237","author":"B Liao","year":"2012","unstructured":"Liao B, Zhao W, Beers DR, Henkel JS, Appel SH. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS. Exp Neurol. 2012;237(1):147\u201352. doi: 10.1016\/j.expneurol.2012.06.011 . Epub 2012 Jun 23.","journal-title":"Exp Neurol"},{"issue":"5","key":"586_CR62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","volume":"81","author":"AE Frakes","year":"2014","unstructured":"Frakes AE, Ferraiuolo L, Haidet-Phillips AM, Schmelzer L, Braun L, Miranda CJ, et al. Microglia induce motor neuron death via the classical NF-kB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81(5):1009\u201323. doi: 10.1016\/j.neuron.2014.01.013 .","journal-title":"Neuron"},{"issue":"3-4","key":"586_CR63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0361-9230(93)90268-G","volume":"30","author":"RG Smith","year":"1993","unstructured":"Smith RG, Engelhardt JI, Tajti J, Appel SH. Experimental immune-mediated motor neuron diseases: models for human ALS. Brain Res Bull. 1993;30(3-4):373\u201380. Review.","journal-title":"Brain Res Bull"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0586-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T15:59:24Z","timestamp":1692374364000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0586-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,24]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0586-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,24]]},"article-number":"121"}}